HempFusion Wellness Inc. Announces Q3 2021 Earnings Release and Investor Call
On November 10, 2021, HempFusion Wellness Inc. (TSX:CBD.U, OTCQX:CBDHF, FWB:8OO) disclosed that it will publish its financial results for the quarter ended September 30, 2021 at 7:00 a.m. Eastern Time on Monday, November 15, 2021. Following the release, the company will host a conference call and live webcast at 8:30 a.m. Eastern Time the same day to discuss performance, strategic initiatives, and outlook.
Details of the Earnings Release
The announcement highlights HempFusion’s commitment to transparency and regulatory readiness. As one of a limited number of CBD-focused firms positioned to meet or exceed anticipated FDA guidance, the company emphasizes its science‑driven approach to product development. According to SPINs market data, HempFusion’s probiotic line, Probulin Probiotics™, ranks among the fastest‑growing probiotic brands in the United States.
HempFusion’s portfolio currently includes 112 SKUs spanning USDA‑Organic Certified tinctures, FDA‑Listed over‑the‑counter topicals, probiotic supplements, skin‑care formulations, a practitioner‑focused line, and a white‑label division. The company reports 43 products in various stages of research and development, underscoring its ongoing investment in innovation.
How to Participate in the Call and Webcast
Investors, analysts, and media can join the live conference call by dialing:
- U.S. and Canada: 877‑545‑0320
- International: 973‑528‑0016
- Entry Code: 664194
The accompanying webcast will be accessible via the following URL: https://www.webcaster4.com/Webcast/Page/2710/43669. An archived audio recording of the webcast will remain available for 90 days after the original broadcast.
About HempFusion Wellness Inc.
HempFusion Wellness Inc. operates as a health‑and‑wellness company that leverages whole‑food hemp nutrition to create premium consumer brands. Its family of brands comprises:
- HempFusion™ – core CBD‑infused supplements and topicals
- Sagely Naturals™ – plant‑based wellness products
- Apothecanna™ – therapeutic topicals and balms
- Probulin Probiotics™ – clinically studied probiotic formulas
With distribution in an estimated 18,000 U.S. retail locations across all 50 states, HempFusion products also reach international markets including China, Mexico, Ireland, the United Kingdom, the United Arab Emirates, South Korea, and Canada. Consumers can purchase directly from each brand’s website, through The Probulin Store on Amazon.com, via Alibaba’s Tmall.com marketplace, and numerous other e‑commerce platforms.
The company’s commitment to scientific rigor is reflected in its robust pipeline of 43 products under development and its adherence to quality standards such as USDA Organic certification and FDA drug‑listing for select OTC topicals.
For further information, visit the corporate website at www.hempfusion.com or follow HempFusion on social media platforms including Twitter, Facebook, and Instagram.
Source: Business Wire press release.
Investor Relations Contact:
Eric Balshin
+1 437‑826‑9911
eric@sophiccapital.com
Company Contact:
Jason Mitchell, N.D.
Chief Executive Officer and Director
ir@hempfusion.com
For the original announcement, see: Here.
